CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $80.04 billion. The enterprise value is $151.96 billion.
| Market Cap | 80.04B |
| Enterprise Value | 151.96B |
Important Dates
The last earnings date was Wednesday, February 12, 2025, before market open.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | Jan 23, 2025 |
Share Statistics
CVS Health has 1.26 billion shares outstanding. The number of shares has decreased by -2.17% in one year.
| Current Share Class | 1.26B |
| Shares Outstanding | 1.26B |
| Shares Change (YoY) | -2.17% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 82.14% |
| Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 17.34 and the forward PE ratio is 10.76. CVS Health's PEG ratio is 0.46.
| PE Ratio | 17.34 |
| Forward PE | 10.76 |
| PS Ratio | 0.22 |
| Forward PS | 0.20 |
| PB Ratio | 1.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.65 |
| P/OCF Ratio | 8.79 |
| PEG Ratio | 0.46 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.05, with an EV/FCF ratio of 24.02.
| EV / Earnings | 32.94 |
| EV / Sales | 0.41 |
| EV / EBITDA | 12.05 |
| EV / EBIT | 18.95 |
| EV / FCF | 24.02 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.09.
| Current Ratio | 0.81 |
| Quick Ratio | 0.56 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | 5.30 |
| Debt / FCF | 13.11 |
| Interest Coverage | 2.71 |
Financial Efficiency
Return on equity (ROE) is 6.02% and return on invested capital (ROIC) is 3.19%.
| Return on Equity (ROE) | 6.02% |
| Return on Assets (ROA) | 1.99% |
| Return on Invested Capital (ROIC) | 3.19% |
| Return on Capital Employed (ROCE) | 4.76% |
| Revenue Per Employee | $1.24M |
| Profits Per Employee | $15,380 |
| Employee Count | 300,000 |
| Asset Turnover | 1.47 |
| Inventory Turnover | 17.79 |
Taxes
In the past 12 months, CVS Health has paid $1.56 billion in taxes.
| Income Tax | 1.56B |
| Effective Tax Rate | 25.41% |
Stock Price Statistics
The stock price has decreased by -16.81% in the last 52 weeks. The beta is 0.61, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -16.81% |
| 50-Day Moving Average | 52.56 |
| 200-Day Moving Average | 57.09 |
| Relative Strength Index (RSI) | 66.19 |
| Average Volume (20 Days) | 12,502,286 |
Short Selling Information
The latest short interest is 21.35 million, so 1.69% of the outstanding shares have been sold short.
| Short Interest | 21.35M |
| Short Previous Month | 18.10M |
| Short % of Shares Out | 1.69% |
| Short % of Float | 1.70% |
| Short Ratio (days to cover) | 1.60 |
Income Statement
In the last 12 months, CVS Health had revenue of $370.66 billion and earned $4.61 billion in profits. Earnings per share was $3.66.
| Revenue | 370.66B |
| Gross Profit | 49.25B |
| Operating Income | 8.02B |
| Pretax Income | 9.63B |
| Net Income | 4.61B |
| EBITDA | 12.62B |
| EBIT | 8.02B |
| Earnings Per Share (EPS) | $3.66 |
Balance Sheet
The company has $10.99 billion in cash and $82.92 billion in debt, giving a net cash position of -$71.93 billion or -$57.05 per share.
| Cash & Cash Equivalents | 10.99B |
| Total Debt | 82.92B |
| Net Cash | -71.93B |
| Net Cash Per Share | -$57.05 |
| Equity (Book Value) | 75.73B |
| Book Value Per Share | 59.97 |
| Working Capital | -15.96B |
Cash Flow
In the last 12 months, operating cash flow was $9.11 billion and capital expenditures -$2.78 billion, giving a free cash flow of $6.33 billion.
| Operating Cash Flow | 9.11B |
| Capital Expenditures | -2.78B |
| Free Cash Flow | 6.33B |
| FCF Per Share | $5.02 |
Margins
Gross margin is 13.29%, with operating and profit margins of 2.16% and 1.24%.
| Gross Margin | 13.29% |
| Operating Margin | 2.16% |
| Pretax Margin | 1.66% |
| Profit Margin | 1.24% |
| EBITDA Margin | 3.40% |
| EBIT Margin | 2.16% |
| FCF Margin | 1.71% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 4.19%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 4.19% |
| Dividend Growth (YoY) | 7.26% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 72.68% |
| Buyback Yield | 2.17% |
| Shareholder Yield | 6.36% |
| Earnings Yield | 5.76% |
| FCF Yield | 7.90% |
Analyst Forecast
The average price target for CVS Health is $69.75, which is 9.88% higher than the current price. The consensus rating is "Buy".
| Price Target | $69.75 |
| Price Target Difference | 9.88% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 5.23% |
| EPS Growth Forecast (5Y) | 23.78% |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.11 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.11 |
| Piotroski F-Score | 4 |